Ercan Tastan
Overview
Explore the profile of Ercan Tastan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soner S, Aktan A, Kilic R, Guzel H, Tastan E, Oksul M, et al.
Pacing Clin Electrophysiol
. 2025 Jan;
48(2):151-159.
PMID: 39868985
Background: Globally, the number of cardiac implantable electronic devices (CIEDs) is increasing. In our study, we aimed to investigate whether CHADS-VASc and RCHADS-VASc scores are predictive of CIED-related complications. Methods:...
2.
Soner S, Aktan A, Kilic R, Guzel H, Tastan E, Oksul M, et al.
BMC Cardiovasc Disord
. 2025 Jan;
25(1):31.
PMID: 39828693
Objective: The triglyceride glucose (TyG) index is a biomarker of insulin resistance and is associated with an increased risk of cardiovascular events. Contrast-induced nephropathy (CIN) is an important complication that...
3.
Soner S, Guzel T, Aktan A, Kilic R, Arslan B, Demir M, et al.
Nutr Metab Cardiovasc Dis
. 2025 Jan;
35(3):103794.
PMID: 39757075
Background And Aim: Many scoring systems are used to evaluate malnutrition, but there is no consensus on which scoring system would be more appropriate. We aimed to investigate the effect...
4.
Oksul M, Bilge O, Turken A, Isik F, Akyuz A, Cap M, et al.
Cureus
. 2023 Mar;
15(2):e34600.
PMID: 36883071
Background: Myotonic dystrophy type 1(MD1), which is characterized by decreased muscle tone, progressive muscle weakness, and cardiac involvement, is an autosomal dominant and progressive congenital muscle disease. Cardiac involvement more...
5.
Tastan E, Inci U
Cureus
. 2022 Oct;
14(8):e28506.
PMID: 36185844
Background Recent studies have demonstrated that the frontal QRS-T angle, defined as the angle between the mean QRS and T vectors, is a strong independent predictor of mortality in patients...
6.
Akyuz A, Cap M, Varsak S, Isik F, Turken A, Tastan E, et al.
J Clin Ultrasound
. 2022 Sep;
50(9):1242-1248.
PMID: 36074078
Purpose: Cardiac involvement in limb-girdle muscular dystrophy (LGMD)2A and LGMD2B, the most common subgroups of LGMD, is controversial. Our study aims to determine whether myocardial dysfunction develops in LGMD2A and...
7.
Bilge O, Komek H, Kepenek F, Tastan E, Gundogan C, Tatli I, et al.
Nucl Med Commun
. 2022 May;
43(7):756-762.
PMID: 35506288
Objective: We aimed to examine the effects of COVID-19 pneumonia on cardiac ischemia detected by myocardial perfusion imaging with single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients presenting...
8.
Bilge O, Cap M, Kepenek F, Erdogan E, Tatli I, Ozturk C, et al.
Acta Cardiol
. 2022 Apr;
77(8):693-698.
PMID: 35451344
Background: Thrombolysis in Myocardial Infarction Frame Count (TFC) is an index that provides a quantitative evaluation of coronary microvascular dysfunction. In this study, we aimed to examine the effect of...
9.
Cap M, Bilge O, Gundogan C, Tatli I, Ozturk C, Tastan E, et al.
Int J Cardiovasc Imaging
. 2021 Nov;
38(2):447-456.
PMID: 34811596
We aimed to examine the effect of a history of COVID-19 on myocardial ischemia in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in patients who presented with shortness...
10.
The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19
Isik F, Cap M, Akyuz A, Bilge O, Aslan B, Inci U, et al.
J Hum Hypertens
. 2021 Aug;
36(9):846-851.
PMID: 34354253
Hypertension is a major concomitant disease in hospitalized patients with COVID-19 (Coronavirus disease 2019) infection. The adverse effect of hypertension on prognosis in COVID-19 is known. Nevertheless, it is not...